Sara De Martin
Papers
1
Total Citations
6
H-Index
1
About
Sara De Martin is a clinical researcher whose work focuses on novel pharmacological interventions for treatment-resistant psychiatric disorders, particularly major depressive disorder (MDD) and dissociative symptoms. Her most cited study, published in 2022, investigates REL-1017 (Esmethadone) as a rapid-acting treatment for dissociative symptoms in adults with MDD who have not responded to standard antidepressants. This work addresses a critical gap in psychiatric care, as dissociative disorders are highly prevalent yet frequently underdiagnosed—affecting an estimated 29% of outpatient psychiatric populations, with only 5% receiving prior diagnosis. De Martin’s research highlights the potential of esmethadone to provide rapid relief for this underserved patient group, offering new hope for those with limited treatment options. Her contributions are particularly impactful given the growing interest in glutamatergic modulators for mood and dissociative disorders. With 6 citations to date, this study represents a foundational step toward validating esmethadone’s efficacy in real-world clinical settings. De Martin’s work underscores the importance of targeting dissociative symptoms within MDD, paving the way for more personalized and effective psychiatric interventions.
Research Focus
Key Achievements
Top Papers
- 1